Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-04

Clinical Trial Update: Epigenetic Regulation of Osteogenesis Imperfecta Severity : miROI Study [NA]

View source ↗

Summary

The miROI study investigating epigenetic regulation of Osteogenesis Imperfecta severity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Osteogenesis Imperfecta | NA | Status: COMPLETED